The FDA cleared the investigational new drug application for ALX2004, with phase 1 trials expected to begin in mid-2025 for ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor ...

2. Large-scale investigation of modifiers of epidermal tumor initiation. We have been successful in combining the pooled-format lentiviral-mediated RNAi and quantitative Illumina sequencing into a ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Surgical delay beyond 42 days after breast cancer diagnosis led to exponential growth in mortality risk for patients with hormone receptor–positive/human epidermal growth factor receptor 2 ...